Zensun was Reported by Media Worldwide
2009-05-11
May 7th, 2009, Thomas Reuters reported Zensun on their Chinese and global websites about Zensun’s IPO plan.
A day before Reuters report, Chinese famous business paper China Business News also reported the history of Zensun’s drug development.
Links:
Reuters China: http://cn.reuters.com/article/companyNews/idCNnCN078359020090507
Reuters: http://www.reuters.com/article/newIssuesNews/idUSSHA12502920090507
China Business News: http://money.163.com/09/0506/02/58JL9LIT00253B0H.html
更多动态
Zensun is Collaborating with The Leibniz-Institut für Alternsforschung-Fritz-Lipmann-Institute.V. to Conduct a Preclinical Study of Neucardin® (recombinant human Neuregulin-1) for The Treatment of Schwannomas
ZENSUN ANNOUNCES THE INVESTIGATION OF NEUCARDIN FOR CHRONIC HEART FAILURE RECEIVES FAST TRACK DESIGNATION FROM THE US FDA
An International Multi-center Phase III Clinical Trial of Recombinant Human Neuregulin-1 is going to
